Jiangsu, China

Zhuo Fang

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
5 patents (USPTO):

Title: Innovations and Contributions of Inventor Zhuo Fang

Introduction

Zhuo Fang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies for tumor immunotherapy. With a total of 5 patents, his work has the potential to advance cancer treatment methodologies.

Latest Patents

Zhuo Fang's latest patents include an innovative anti-CD47/anti-PD-1 bispecific antibody. This invention relates to a preparation method and its use, which involves a first antigen binding portion that specifically binds to CD47 and a second antigen binding portion that binds to PD-1. This bispecific antibody can effectively block two mechanisms of tumor immune escape, showcasing its promise in tumor immunotherapy. Another significant patent is the humanized anti-human OX40 monoclonal antibody, which also includes a preparation method and its applications. This antibody has high affinity and specificity for OX40, stimulating T cells to secrete cytokines and enhancing immune regulation, thereby contributing to effective tumor immunotherapy.

Career Highlights

Zhuo Fang has worked with prominent companies in the biotechnology sector, including Nanjing Genscript Biotech Co., Ltd. and Nanjing Legend Biotech Co., Ltd. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Zhuo Fang has collaborated with notable colleagues, including Liusong Yin and Tielin Zhou. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Zhuo Fang's contributions to biotechnology, particularly in the realm of tumor immunotherapy, highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving cancer treatment options, making him a significant figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…